Accanto Partners
VC Fund
Belvedere Tiburon, United States
Accanto Partners is a VC fund in Belvedere Tiburon focused on SaaS and Software. Accanto Partners primarily invests in tech startups to provide support to founders as they grow their companies.
- Total investments:
- 11
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Accanto Partners invests in
SaaSSoftwareHealth CareRetailLogistics
Stages Accanto Partners invests in
Series ASeedSeries BSeries CSeries D
Countries Accanto Partners invests in
United States
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Bob Doris
|
|||
Elizabeth Haviland
|
|||
Mary Sauer
|
|||
Paul Norris
|
|||
Investment Focus
Industry
- SaaS 3 (27%)
- Software 3 (27%)
- Health Care 2 (18%)
- Retail 1 (9%)
- Logistics 1 (9%)
Stage
- Series A 3 (27%)
- Seed 2 (18%)
- Series B 1 (9%)
- Series C 1 (9%)
- Series D 1 (9%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Bob Doris
Founding Partner
|
Founding Partner | Total investments: 1 | Find email | |
|
Elizabeth Haviland
Vice President
|
Vice President | Total investments: 0 | Find email | |
|
Mary Sauer
Co-Founder
|
Co-Founder | Total investments: 0 | Find email | |
|
Paul Norris
Partner
|
Partner | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Avisi Technologies
|
Avisi Technologies develops ophthalmic medical devices using nanotechnology to address vision loss associated with glaucoma and related eye conditions. The company designs implantable solutions such as VisiPlate, an aqueous shunt that regulates intraocular fluid through microchannel structures to help manage eye pressure. Its work combinesmaterials science and ophthalmology to create minimally invasive devices intended for long-term function within the eye. | $10.8M / Series A / Feb 25, 2026 | |
Adaptilens
|
Adaptilens develop an accommodating intraocular lens. Adaptilen's mission is to bring to market an accommodative intraocular lens that mimics the natural human lens so that patients will have excellent near and distance vision without eyeglasses or contact lenses. | $17.5M / Series A / Apr 29, 2024 | |
|
Avisi Technologies
|
Avisi Technologies develops ophthalmic medical devices using nanotechnology to address vision loss associated with glaucoma and related eye conditions. The company designs implantable solutions such as VisiPlate, an aqueous shunt that regulates intraocular fluid through microchannel structures to help manage eye pressure. Its work combinesmaterials science and ophthalmology to create minimally invasive devices intended for long-term function within the eye. | $6.3M / Seed / Oct 01, 2023 | |
Constellation
|
Constellation is a global, NYC-based SaaS company that’s seen exponential growth since its founding in 2016. Inventing the world’s first and only creative marketing technology made for highly regulated industries, our end-to-end compliance solution features built-in verticalized engines designed to streamline the creative process for Fortune 500companies in Auto, Pharma and Banking—with an automated solution that scales both creative and the regulatory approval process.Constellation was named the 65th Fastest-Growing Private Company in America, the 10th Fastest-Growing Women-Owned Private Company, and the 7th Fastest-Growing Marketing & Advertising Company by Inc 500. In 2022, our platform won the Digiday Technology Award for Best Marketing Automation Platform. | $15M / Private Equity / Dec 21, 2022 | |
|
Adaptilens
|
Adaptilens develop an accommodating intraocular lens. Adaptilen's mission is to bring to market an accommodative intraocular lens that mimics the natural human lens so that patients will have excellent near and distance vision without eyeglasses or contact lenses. | $1.6M / Seed / Nov 12, 2020 | |
Catalant
|
Catalant is a software company that provides global enterprises with software solutions to access business expertise on demand. The company helps more than 30% of the Fortune 100 get from strategy to execution faster, with software that helps businesses accelerate mission-critical work and more than 65,000 experts and 1,000 firms who help themdeliver it.Catalant platform is designed to enable the process of strategy execution, starting with entering in a business’ most important strategic objectives, aligning work and breaking it down into distinct elements, accessing and deploying needed internal and external resources, collaborating to execute it, measuring the work’s value, and providing insights to keep improving how it all gets done. It has built a global network of more than 27,000 boutique firms, custom teams, and independent experts, as well as best-in-class software tools for engaging and managing this market.Catalant is headquartered in Boston, Massachusetts, and serves customers around the world. | $35M / Series E / Jan 22, 2020 | |
BevSpot
|
BevSpot provides food and beverage management software for inventory, ordering, invoicing, and access to clients' establishment’s critical sales data. | $5.4M / Oct 01, 2018 | |
|
Catalant
|
Catalant is a software company that provides global enterprises with software solutions to access business expertise on demand. The company helps more than 30% of the Fortune 100 get from strategy to execution faster, with software that helps businesses accelerate mission-critical work and more than 65,000 experts and 1,000 firms who help themdeliver it.Catalant platform is designed to enable the process of strategy execution, starting with entering in a business’ most important strategic objectives, aligning work and breaking it down into distinct elements, accessing and deploying needed internal and external resources, collaborating to execute it, measuring the work’s value, and providing insights to keep improving how it all gets done. It has built a global network of more than 27,000 boutique firms, custom teams, and independent experts, as well as best-in-class software tools for engaging and managing this market.Catalant is headquartered in Boston, Massachusetts, and serves customers around the world. | $41M / Series D / Jun 27, 2017 | |
|
BevSpot
|
BevSpot provides food and beverage management software for inventory, ordering, invoicing, and access to clients' establishment’s critical sales data. | $11M / Series B / Jul 07, 2016 | |
|
Catalant
|
Catalant is a software company that provides global enterprises with software solutions to access business expertise on demand. The company helps more than 30% of the Fortune 100 get from strategy to execution faster, with software that helps businesses accelerate mission-critical work and more than 65,000 experts and 1,000 firms who help themdeliver it.Catalant platform is designed to enable the process of strategy execution, starting with entering in a business’ most important strategic objectives, aligning work and breaking it down into distinct elements, accessing and deploying needed internal and external resources, collaborating to execute it, measuring the work’s value, and providing insights to keep improving how it all gets done. It has built a global network of more than 27,000 boutique firms, custom teams, and independent experts, as well as best-in-class software tools for engaging and managing this market.Catalant is headquartered in Boston, Massachusetts, and serves customers around the world. | $22M / Series C / Jul 05, 2016 | |
| See all 11 investments → | |||
Co-Investors
GE Ventures
3 deals together
Good Growth Capital
2 deals together
Life Sciences Greenhouse of Pennsylvania
2 deals together
MedVenture Partners
2 deals together
Pillar VC
2 deals together
380 Cap
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
SaaS Investors
99,274 investors
Software Investors
50,021 investors
Health Care Investors
43,014 investors
Marketplace Investors
40,654 investors
Transportation Investors
27,893 investors
Retail Investors
12,193 investors
SaaS VC Funds
61,208 investors
Software VC Funds
31,919 investors
Health Care VC Funds
32,370 investors
FAQ
What does Accanto Partners invest in?
Accanto Partners invests primarily in SaaS, Software and Health Care startups, most often at Series A and Seed stage. Most of the 11 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Accanto Partners?
Public channels for Accanto Partners include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Accanto Partners?
The team at Accanto Partners includes Bob Doris (Founding Partner), Elizabeth Haviland (Vice President) and Mary Sauer (Co-Founder). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
